The current investigation was intended to elucidate the molecular mechanism of α-Mangostin in the regulation of pancreatic cancer stem cell (CSC) characteristics.
| INTRODUC TI ON
Pancreatic cancer is a devastating disease and is the fourth most common cause of cancer-related mortality in the United States.
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Pancreatic cancer exhibits the poorest prognosis from all other cancers, and the overall 5-year survival rate continues to be less than 6%. 2, 3 Pancreatic cancer is characterized by slow growth, late detection and resistance to chemotherapy and radiation and is associated with high mortality rates even after surgery. 3 Unfortunately, by the time the disease is diagnosed most of the pancreatic cancer patients present with unresectable advanced malignancy due to early metastasis. Accumulating evidence supports the role of cancer stem cells (CSCs) in cancer initiation, progression, metastasis and chemotherapy failure. 4 Despite increased advancement in our understanding of the disease progression, diagnosis and therapeutics, available treatment options are limited. Chemo-and radio-therapies have been largely ineffective and associated with enhanced drug toxicity, drug resistance and frequent redevelopment of the metastatic disease.
Further, poor bioavailability of the drug and undesirable side effects are other significant limitations in the effective management of pancreatic cancer. Thus, it is highly desirable to develop an increased understanding of the pathogenesis of the disease, for effective disease management and the development of effective strategies by non-toxic natural agents for the prevention and treatment of pancreatic cancer.
Hedgehog (Hh) signalling pathway is crucially involved in vertebrate development. 5 It is inactive in mature cells of normal adult and found to be aberrantly hyper-activated in pancreatic cancer and various other malignancies. Evidence suggests that Hh signalling can regulate tissue homeostasis by controlling the production of stem or progenitor cells. 6 Deregulation of the Hh signalling pathway is as- Several reports have demonstrated that Hh pathway activation induces stem cell markers and is involved in the enhancement of epithelial-to-mesenchymal transition (EMT) thus regulating metastasis in various malignancies including pancreatic ductal adenocarcinoma. 5, 13 The involvement of Shh increases dramatically from PanIN lesions to PDAC to metastatic tumours. 14 Therefore, targeting the Shh pathway is regarded as a beneficial strategy for the prevention and treatment of pancreatic cancer.
Wnt, Shh and several other extrinsic developmental pathways play significant roles in the maintenance and regulation of pluripotency and self-renewal capacity of progenitor and stem cells. 15 Nanog is a transcription factor which is one of the crucial downstream effectors of these signalling pathways and also a direct transcriptional target of Gli. 16, 17 Nanog modulates pluripotency, maintain self-renewal and block differentiation. 18 Nanog is expressed highly in germline stem cells, tumours, carcinomas and seminomas. 19, 20 In addition to Gli, various other transcription factors such as Oct4, FoxD3 and P53 can regulate Nanog transcription. 21, 22 Interestingly, Nanog can cooperate with Oct4 and Sox2 in maintaining self-renewal capacity and pluripotency in stem cells. 23 As Nanog is a direct target of the Shh pathway, we will examine the regulation of Shh-Nanog pathway by α-Mangostin in pancreatic CSCs.
As natural product-based compounds are non-toxic, can target multiple pathways and can negatively impact the self-renewal ca- 
| Cell culture
Pancreatic cancer cell lines AsPC-1 and PANC-1 were used, and these cells were purchased from American Type Culture Collection harbours mutation on codon 12 of K-ras gene. CD133+/CD44+/ CD24+/ESA+human pancreatic CSCs were isolated from primary tumours as described previously. 26 Pancreatic CSCs isolation and characterization from KrasG12D mice were performed as described elsewhere. 26 Pancreatic CSCs were grown in specialized growth medium (Celprogen, Inc, Torrance, California) which contained 1% N2 Supplement (Invitrogen), 2% B27 Supplement (Invitrogen), 20 ng/mL human platelet growth factor (Sigma-Aldrich), 100 ng/mL epidermal growth factor (Invitrogen) and 1% antibiotic-antimycotic (Invitrogen).
Pancreatic CSCs and cancer cell lines were cultured at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
| Cell proliferation and apoptosis assays
Pancreatic cancer cells and CSCs (1.5 × 10 4 ) in 1 mL of culture medium were incubated for 24 to 48 hours time-points with various concentrations of 0-10 µmol/L of α-Mangostin. Cell viability and apoptosis were measured by trypan blue assay using Countess™ Automated Cell Counter (Invitrogen) and TUNEL assay respectively. 
| Colony formation assay
For colony formation assay, pancreatic cancer cells and CSCs were seeded at a low density into 6-well plates and then treated with or without α-Mangostin for up to 2 weeks. Cell culture medium containing either α-Mangostin or DMSO was renewed every 3 days.
After fixation of the colonies with cold methanol, 0.5% crystal violet was used to stain them. The colonies were imaged with a microscope, and the number of colonies was counted.
| Spheroid assay
We performed spheroid formation assays as described elsewhere.
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Briefly, cells at 100-500 cells/mL density were plated in ultra-low attachment plates. The spheroid formation in suspension was evaluated under a microscope after 10 days of culture.
| Motility, transwell migration and invasion assays
Assays for cell motility, transwell migration and invasion have been performed as we described elsewhere. 
| Gene expression by quantitative RT-PCR analysis
Total RNA in cells was isolated using TRIzol reagent (Invitrogen).
About 2 μg of the extracted RNA was reverse transcribed into cDNA using High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). qRT-PCR was carried out using fast SYBR Green Master Mix (Thermo Fisher Scientific). Relative mRNA expressions were compared with controls and evaluated using 2 −ΔΔCt methods. protocol. For reuse, the blots were washed in stripping buffer for 30-60 minutes at room temperature.
| Western blot analysis

| Chromatin immunoprecipitation (ChIP)
Pancreatic CSCs were treated with various doses of α-Mangostin, crosslinked and sonicated. The crosslinked sheared chromatin samples were then incubated with 3 μg of Nanog antibody and 5 μL of protein-A and protein-G magnetic beads. The ChIP DNA was further purified, and 1-3 µL elutions were used to measure enrichment using quantitative real-time PCR. ChIP-derived DNA was electrophoresed on 2% agarose gels.
| Gli and Nanog reporter assay
Measurement of Gli and Nanog reporter activities was performed as we described elsewhere. 7, 31 In brief, pancreatic cancer cells were stably transduced with lentiviral particles expressing cop-GFP and luciferase genes (pGreen Fire1-4xGli or Nanog-mCMV-EF1-Neo).
The cells for transcription assay were seeded in 96-well plates and treated with or without α-Mangostin (0-10 µmol/L) for various time-points. According to the manufacturer's instructions (Promega Corp., Madison, WI), luciferase reporter activity was measured at the end of incubation period.
| Statistical analysis
The results presented are representative of three independent experiments run in triplicate, unless otherwise indicated. Student t test or ANOVA was used to analyse the differences between groups.
Differences among groups were considered significant at P < 0.05.
| RE SULTS
| α-Mangostin negatively impacts on cell
proliferation and is associated with the induction of apoptosis in pancreatic CSCs and cell lines and has no effect on immortalized human pancreatic normal ductal epithelial cells have the potential to be used in the prevention and treatment of pancreatic cancer.
| α-Mangostin targets the pancreatic CSCs selfrenewal capacity, stemness and inhibits spheroid and colony formation
A significant characteristic of CSC is its ability to form spheroids in suspension which is reflective of its capability of stemness, reconstitution and propagation of tumours. 8, 32 Thus, to examine F I G U R E 2 α-Mangostin inhibits cell viability in spheroids, and colony formation and the expression of stem cell markers and pluripotency maintain factors by CSCs from pancreatic tumours. (A and B), CSCs were isolated from pancreatic tumours of humans and KrasG12D mice and treated with α-Mangostin (0-10 µmol/L) for 7 d to obtain primary spheroids. At the end of the incubation period for a week, the spheroids were collected, reseeded and treated with α-Mangostin for another week to obtain secondary spheroids. Further, secondary spheroids were collected, reseeded and treated with α-Mangostin for another week to obtain tertiary spheroids. Cell viability in the spheroids was measured by trypan blue assay at the end of 
| Inhibitory effects of α-Mangostin on Shh signalling pathway and Gli transcriptional targets
We have demonstrated that Shh signalling pathway is highly activated in pancreatic cancer. 7, 11, 33 We examined the expression of Shh pathway components to analyse the effects of α-Mangostin in pancreatic CSCs. Gli1, Gli2, Patched1, Patched2 and smoothened protein expression was inhibited by α-Mangostin as measured using
Western blot analysis ( Figure 3A) . As Gli can regulate its own expression as well as the expression of Patched as they are both its direct transcriptional targets. To examine the effects of α-Mangostin, we next measured the Gli transcriptional activity using luciferase reporter assay. As demonstrated in (Figure 3B ), Gli reporter activity was inhibited in a dose-dependent manner by α-Mangostin. These data suggest that α-Mangostin inhibits survival of pancreatic cancer cells by facilitating the inhibition of Shh pathway components and Gli target proteins.
Cell proliferation and cell cycle play crucial roles in maintaining the CSC population, we thus measured the expression of Bcl-2 and Cyclin D1 ( Figure 3C ). Cyclin D1 acts at the G1/S phase of the cell cycle. α-Mangostin inhibited Bcl-2 and Cyclin D1 protein expression suggesting that α-Mangostin can inhibit cell proliferation and cell cycle and induce apoptosis by regulating these critical factors.
F I G U R E 3 α-Mangostin inhibits the components of the sonic hedgehog (Shh) pathway, Gli transcription and markers of cell proliferation and cell cycle. A, Pancreatic CSCs were treated with α-Mangostin (0-10 µmol/L) for 48 h. The expression of Gli1, Gl2, Patched-1, Patched-2 and smoothened was measured by the Western blot analysis. β-actin was used as a loading control. B, Gli-responsive GFP/firefly luciferase viral particles were used to transduce pancreatic CSCs (pGreen Fire1-Gli with EF1, System Biosciences). After transduction, the culture medium was replaced, and CSCs were treated with α-Mangostin (0-10 µmol/L) for 24 h. Gli reporter activity was measured as we described elsewhere. 16 *, #, % and @ = significantly different from control, and each other, P < 0.05. C, α-Mangostin inhibits the expression of Bcl-2 and cyclin D1. Pancreatic CSCs were treated with α-Mangostin (0-10 µmol/L) for 48 h, and the expression of Bcl-2 and cyclin D1 was measured by the Western blot analysis. β-actin was used as a loading control
| α-Mangostin inhibits binding of Nanog to its target genes (Cdk2, Cdk6, FGF4, c-Myc and Oct4) and Nanog transcription
In the maintenance of self-renewal and pluripotency, Nanog is considered to play a critical role. We have demonstrated increased levels of Nanog expression in pancreatic CSCs and cell lines. As Nanog is a transcription factor, the effects of α-Mangostin on Nanog binding to the promoters of its target genes were examined. We performed chroma- As Nanog is also a direct transcriptional target of Gli. To investigate the effects of α-Mangostin on Nanog transcription, we measured the luciferase reporter activity. In pancreatic CSCs, AsPC-1
and PANC-1 cell lines, α-Mangostin significantly inhibited the Nanog reporter activity ( Figure 5 ). Thus, taken together, these results suggest that α-Mangostin regulates pluripotency-, cell survival-and cell cycle-related genes by modulating Cdk2, Cdk6, FGF4, c-Myc and Oct4 expression through Nanog.
| Inhibitory effects of α-Mangostin on cell motility, migration, invasion and markers of epithelialmesenchymal transition
For metastasis to occur, EMT becomes inevitable in which cancer cells acquire genetic changes that equip them to migrate to distant organ sites where they can reestablish and proliferate. 34, 35 As
CSCs are associated with the metastasis and treatment resistance, 
| D ISCUSS I ON
In the current study, we demonstrate that α-Mangostin inhibits pancreatic CSC characteristics through Shh-Nanog pathway. growth by suppressing the Shh-Gli pathway. [8] [9] [10] [11] 32, [36] [37] [38] [39] In the pres- 
F I G U R E 7
Enforced activation of the Shh pathway or Nanog overexpression abrogated inhibitory effects of α-Mangostin on cell proliferation and Gli or Nanog transcription and expression respectively. A, Pancreatic CSCs were pretreated with Shh protein (100 nmol/L) for 2 h followed by treatment with α-Mangostin (5 µmol/L) for 48 hrs. Cell proliferation was measured by trypan blue assay. Data represent mean (n = 4) ± SD. *, or % = significantly different from control, P < 0.05. B, Using Gli-responsive GFP/firefly luciferase viral particles (pGreen Fire1-Gli with EF1, System Biosciences), pancreatic CSCs were transduced. After transduction, CSCs were pretreated with Shh protein for 2 h followed by treatment with α-Mangostin for 24 h. Gli transcription was measured by luciferase assay as we described elsewhere. 15 Data represent mean (n = 4) ± SD. *, or % = significantly different from control, P < 0.05. C, Pancreatic CSCs were pretreated with Shh protein (100 nmol/L) for 2 h followed by treatment with α-Mangostin (5 µmol/L) for 48 h. The expression of Gli1 was measured by q-RT-PCR. Data represent mean (n = 4) ± SD. *, or % = significantly different from control, P < 0.05. D, Pancreatic CSCs were transduced with lentiviral particles expressing either empty vector or Nanog cDNA. The expression of Nanog was measured by q-RT-PCR. Data represent mean (n = 4) ± SD. * = significantly different from control, P < 0.05. E, Pancreatic CSCs were transduced with lentiviral particles containing either empty vector or Nanog cDNA and treated with Mang (5 µmol/L) for 48 h. Cell proliferation was measured by trypan blue assay. F, Pancreatic CSCs (CSCs/Empty vector and CSCs/Nanog cDNA) were transduced with Nanog-responsive GFP/firefly luciferase viral particles (pGreen Fire1-Nanog with EF1). After transduction, CSCs were treated with Mang for 24 h. Nanog transcription was measured by luciferase assay as we described elsewhere. 15 EMT. Snail has been shown to bind to the E-cadherin promoter at the E-box site and thus can repress the transcription of E-cadherin transcription. 43 Further, it has been reported that Snail also stimulates the transcription of mesenchymal genes such as N-cadherin and Vimentin and thus regulate their expressions.
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In conclusion, we demonstrate here that α-Mangostin inhibits pancreatic CSC characteristics and cancer cell growth through the inhibition of Shh-Gli pathway. α-Mangostin inhibits Gli transcription, and its target genes Nanog, Oct4, c-Myc, Sox2 and KLF4.
α-Mangostin not only inhibited smoothened but also Gli transcription. Therefore, α-Mangostin has an additional clinical advantage, that is, if the pancreatic cancer patients develop resistance to smoothened inhibition due to mutation(s) on the smoothened receptors, they will be able to respond to α-Mangostin because it also inhibits the expression of effector molecule Gli. Therefore, targeting the Shh-Gli pathway through dual inhibition (smoothened and Gli) by α-Mangostin could have enormous clinical significance for pancreatic cancer initiation, progression, metastasis and tumour growth. Overall, our study suggests that α-Mangostin can be used for the treatment and prevention of pancreatic cancer by targeting CSCs.
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